BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9766876)

  • 1. Trace analysis of SN-38 in human plasma by high-performance liquid chromatography.
    Rivory LP; Findlay M; Clarke S; Bishop J
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):355-9. PubMed ID: 9766876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma.
    Owens TS; Dodds H; Fricke K; Hanna SK; Crews KR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):65-74. PubMed ID: 12668072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    de Bruijn P; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):277-85. PubMed ID: 9367218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry.
    Ragot S; Marquet P; Lachâtre F; Rousseau A; Lacassie E; Gaulier JM; Dupuy JL; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):175-84. PubMed ID: 10676997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT.
    Kurita A; Kaneda N
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(2):335-44. PubMed ID: 10219676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
    Park DJ; Won JH; Cho AR; Yun HJ; Heo JH; Hwhang TH; Lee DH; Kim WM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():147-152. PubMed ID: 24927278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.
    Rivory LP; Robert J
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):133-41. PubMed ID: 7866541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination by liquid chromatography with fluorescence detection of total 7-ethyl-10-hydroxy-camptothecin (SN-38) in beagle dog plasma after intravenous administration of liposome-based SN-38 (LE-SN38).
    Guo W; Ahmad A; Khan S; Dahhani F; Wang YF; Ahmad I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):85-92. PubMed ID: 12798168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.
    Barilero I; Gandia D; Armand JP; Mathieu-Boué A; Ré M; Gouyette A; Chabot GG
    J Chromatogr; 1992 Mar; 575(2):275-80. PubMed ID: 1629304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasma.
    Sumiyoshi H; Fujiwara Y; Ohune T; Yamaoka N; Tamura K; Yamakido M
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):309-16. PubMed ID: 8548021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic-tandem mass spectrometric assay for the simultaneous quantification of Camptosar and its metabolite SN-38 in mouse plasma and tissues.
    Bardin S; Guo W; Johnson JL; Khan S; Ahmad A; Duggan JX; Ayoub J; Ahmad I
    J Chromatogr A; 2005 May; 1073(1-2):249-55. PubMed ID: 15909526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
    Schoemaker NE; Rosing H; Jansen S; Schellens JH; Beijnen JH
    Ther Drug Monit; 2003 Feb; 25(1):120-4. PubMed ID: 12548157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography.
    de Bruijn P; de Jonge MJ; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    Anal Biochem; 1999 Apr; 269(1):174-8. PubMed ID: 10094790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies.
    Escoriaza J; Aldaz A; Castellanos C; Calvo E; Giráldez J
    J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):159-68. PubMed ID: 10821401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of irinotecan and its metabolite SN-38 in dried blood spots using high-performance liquid-chromatography with fluorescence detection.
    Hahn RZ; Arnhold PC; Andriguetti NB; Schneider A; Klück HM; Dos Reis SL; Bastiani MF; Kael I; da Silva ACC; Schwartsmann G; Antunes MV; Linden R
    J Pharm Biomed Anal; 2018 Feb; 150():51-58. PubMed ID: 29216585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive HPLC-fluorescence method for irinotecan and four major metabolites in human plasma and saliva: application to pharmacokinetic studies.
    Poujol S; Pinguet F; Malosse F; Astre C; Ychou M; Culine S; Bressolle F
    Clin Chem; 2003 Nov; 49(11):1900-8. PubMed ID: 14578322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
    Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analytical method for irinotecan (CPT-11) and its metabolites using a high-performance liquid chromatography: parallel detection with fluorescence and mass spectrometry.
    Sai K; Kaniwa N; Ozawa S; Sawada J
    Biomed Chromatogr; 2002 May; 16(3):209-18. PubMed ID: 11920947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and kinetics of a beta-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan.
    Rivory LP; Robert J
    Cancer Chemother Pharmacol; 1995; 36(2):176-9. PubMed ID: 7767955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Talanta; 2008 Sep; 76(5):1015-21. PubMed ID: 18761148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.